Skip to main content
. 2014 Nov 17;168(6):796–805. doi: 10.1111/bjh.13214

Table III.

Adverse events occurring as any grade in ≥20% or as grade ≥3 in ≥5% of all patients

Grade Schedule A* (= 29) Schedule B (= 35) Schedule C72 (= 29) Schedule C90§ (= 20) All patients (= 113)
Any ≥3 Any ≥3 Any ≥3 Any ≥3 Any ≥3
Haematological events, %
 Febrile neutropenia 48 35 66 60 62 55 50 45 58 50
 Thrombocytopenia 45 45 69 69 69 62 60 60 61 59
 Anaemia 41 38 54 46 66 55 60 60 55 49
 Neutropenia 41 38 26 26 28 28 25 25 30 29
 Leucopenia 7 7 14 14 0 0 5 5 7 7
Non-haematological events, %
 Cardiac disorders
  Tachycardia 38 0 40 0 17 0 25 5 31 1
 Gastrointestinal disorders
  Diarrhoea 83 7 77 6 69 0 65 10 74 5
  Stomatitis/oral mucositis 72 28 57 11 55 28 55 25 60 22
  Nausea 76 3 60 0 86 3 55 5 70 3
  Vomiting 55 0 29 0 52 7 25 0 41 2
  Constipation 41 0 37 0 17 0 20 0 30 0
  Oral pain 7 3 14 3 17 10 30 15 16 7
 General disorders/administration site conditions
  Peripheral oedema 59 10 49 3 52 3 40 0 50 4
  Fatigue 52 17 57 20 41 14 35 15 48 17
  Asthenia 31 10 40 9 21 7 10 0 27 7
  Chills 28 0 34 0 28 3 30 0 30 1
  Pyrexia 17 0 26 3 24 0 35 0 25 1
 Infections and infestations
  Aggregate sepsis 52 55** 43 34** 21 24 45 45** 40 39**
  Aggregate infections 45 21 37 6** 45 10 35 20 41 13**
  Aggregate pneumonia 41 31** 40 34** 38 28 35 25** 39 30**
 Metabolism and nutrition disorders
  Anorexia 72 28 51 9 59 10 55 0 59 12
  Hypokalaemia 72 41 54 20 59 21 65 15 62 25
  Hypomagnesaemia 52 3 40 0 48 0 30 0 43 1
  Hypophosphataemia 45 24 23 3 21 7 25 15 28 12
  Dehydration 28 14 20 0 10 3 25 15 20 7
  Hypocalcaemia 28 14 14 6 31 10 20 10 23 10
  Hyperglycaemia 10 7 20 6 21 10 15 5 17 7
 Nervous system disorders
  Headache 35 0 26 3 31 3 10 0 27 2
  Dizziness 21 0 20 0 24 0 20 0 21 0
 Psychiatric disorders
  Insomnia 41 0 37 0 38 0 15 0 35 0
  Confusional state 28 14 26 0 28 3 10 5 24 5
  Anxiety 24 0 40 0 41 3 20 0 33 1
 Respiratory, thoracic, and mediastinal disorders
  Cough 45 0 31 0 38 0 25 0 35 0
  Dyspnea 38 24 40 9 38 3 25 15 36 12
  Rales 35 0 23 0 7 0 15 0 20 0
  Epistaxis 24 0 37 0 28 7 25 0 29 2
  Pleural effusion 24 0 23 9 38 0 10 0 25 3
  Hypoxia 10 7 17 14 21 3 10 0 15 7
 Skin and subcutaneous tissue disorders
  Alopecia 41 0 23 0 45 0 25 0 34 0
  Petechiae 28 0 31 0 14 0 0 0 20 0
  Rash 24 0 23 0 35 3 15 0 25 1
 Vascular disorders
  Hypotension 38 17 31 3 35 0 30 15 34 8
  Hypertension 21 10 11 9 10 3 0 0 12 6
*

72 mg/m2 on days 1, 8, and 15.

72 mg/m2 on days 1 and 8.

72 mg/m2 on days 1 and 4.

§

90 mg/m2 on days 1 and 4.

Aggregate sepsis includes sepsis, bacteraemia, viraemia and fungaemia, and represents 32 preferred terms; aggregate infections represent 30 preferred terms; aggregate pneumonia represents 10 preferred terms.

**

Includes 1 or more grade 5 events. Grade 5 aggregate sepsis was observed with schedules A (= 4), B (= 3), and C90 (= 2); grade 5 aggregate pneumonia was observed with Schedules A (= 1), B (n = 1), and C90 (= 2); grade 5 aggregate infection was observed with Schedule B (= 1).